Featured Article
Ancient viral infections that occurred hundreds of thousands of years ago, so called “fossil viruses,” now found in thousands of human DNA sequences have been linked with major psychiatric disorders according to an international research collaboration led by investigators at King’s College London (KCL).
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Ambry, PacBio, and GREGoR Join for Major Rare Disease Sequencing Project
Ambry Genetics and PacBio will work with the University of California, Irvine (UCI) and the GREGoR Consortium to use long-read technology to sequence and analyze up to 7,000 human whole genomes over three years and seek new insights into rare disease etiology.
COVID Advances Could Transform Personalized Medicine
Innovations in big data and new technology brought on by the COVID pandemic could revolutionize personalized medicine, scientists maintain.
New Biomarkers Discovered for Early Prediction of Kidney Failure in Type 1 Diabetes Patients
Using multiomics analysis, scientists have identified epigenetic biomarkers, predicting the risk of kidney failure in diabetes patients.
